Diagnostic Value of eVOG

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Mar 17, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new eye movement recording technology called eVOG, which stands for mobile VideoOculoGraphy. The aim is to see if eVOG can help detect subtle eye movement issues in patients with multiple sclerosis (MS) or related conditions. These eye movement problems can sometimes occur without other obvious symptoms, making early diagnosis challenging. Participants in the study will include adults over 18 who are being evaluated for specific brain changes seen on MRI scans, but who do not show eye movement problems during standard clinical exams.

If you join the trial, you will undergo eye movement tests using the eVOG app, which is designed to measure how well your eyes move in various directions. The hope is that this new technology will identify eye movement disorders more effectively than traditional methods. The trial is currently recruiting participants, so if you or someone you know meets the eligibility criteria, it could be a valuable opportunity to contribute to important research in understanding and diagnosing MS-related conditions.

Gender

ALL

Eligibility criteria

• Patients Inclusion Criteria:
• • Patients referred to our tertiary center for a diagnostic workup of white matter hypersignals
• • Absence of oculomotor disorders on conventional clinical examination
• • Age \> 18 years
• controls Inclusion criteria:
• • The controls can be recruited from the accompanying persons of the patients selected for the study, from the staff of the CHU of Nice or from the entourage of the investigating team;
• • Absence of known oculomotor disorders by the control
• • Age \> 18 years
• Exclusion Criteria:
• • Presence of a neurological, ophthalmological or general pathology that may interfere with the performance of digital video oculography